OrvilleGKoltermanMD
Endocrinology • San Diego, CADiabetes, Lipid Metabolism
Biopharmaceutical Consultant. Preventative Cardiology
Dr. Kolterman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
San Diego, CA 92103Phone+1 858-657-8000Fax+1 858-552-8984
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1976 - 1978
University of ChicagoResidency, Internal Medicine, 1974 - 1976
Stanford University School of MedicineClass of 1974
Certifications & Licensure
IL State Medical License 1975 - Present
CA State Medical License 1976 - 2025
CO State Medical License 1978 - 1985- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Dose Comparisons of Leucine-Metformin Combinations on Blood Glucose Levels In Type 2 Diabetic Patients Start of enrollment: 2014 Jul 01
- Placebo-Controlled Clinical Nutrition Study of the Safety and Metabolic Effects of Two Medical Foods in Type 2 Diabetes Start of enrollment: 2017 Oct 22
- Placebo-Controlled Clinical Nutrition Study of the Metabolic Effects of Food Product WBF-0011 in Type 2 Diabetes Start of enrollment: 2019 Aug 06
- Join now to see all
Publications & Presentations
PubMed
- 19 citationsIncreased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes.Paul J McMurdie, Magdalena K Stoeva, Nicholas Justice, Madeleine Nemchek, Christian M K Sieber
BMC Microbiology. 2022-01-08 - 231 citationsRole of Hyperglucagonemia in Maintenance of Increased Rates of Hepatic Glucose Output in Type II DiabeticsAlain D. Baron, Linda Schaeffer, Paul Shragg, Orville G. Kolterman
Diabetes. 1987-03-01 - 56 citationsPramlintide: a human amylin analogue reduced postprandial plasma glucose, insulin, and C-peptide concentrations in patients with type 2 diabetes.R. G. Thompson, Alan Gottlieb, K. Organ, Joy E. Koda, J. Kisicki
Diabetic Medicine. 1997-07-01
Press Mentions
How to Recognize the Early Signs and Symptoms of DiabetesAugust 6th, 2021- New Report Explains Microbiome Impact on Glucose ControlJune 28th, 2021
- Modular Medical Establishes a Distinguished Multi-Disciplinary Advisory BoardMarch 18th, 2021
- Join now to see all
Grant Support
- Epidemiology Of Diabetes Intervention And ComplicationsNational Center For Research Resources2004–2010
- Genetics Of Diabetes And Diabetic ComplicationsNational Center For Research Resources2004–2005
- Epidemiology Of Diabetes Intervention And ComplicationNational Center For Research Resources1995–2002
- Plasma Amylin Profiles In Response To An Oral Glucose LoadNational Center For Research Resources1996–1997
- Diabetes Control And Complications Trial Family StudyNational Center For Research Resources1995
- Diabetes Control And Complications TrialNational Center For Research Resources1995
- Diabetes Control And Complications TrialNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1993
- Diabetes Control And Complications Trial (DCCT)National Institute Of Diabetes And Digestive And Kidney Diseases1987–1988
- Post Prandial Plasma Glucose InsulinNational Center For Research Resources1985–1986
- Mechanism Of Insulin Resistance In ObesityNational Center For Research Resources1985–1986
- Insulin Binding To Human AdipocytesNational Center For Research Resources1985–1986
- Genetic/Endocrine Study Of Medullary Cell Carcinoma Of Multiple NeurofibromatosisNational Center For Research Resources1985–1986
- Effect Of Insulin Therapy On Insulin Resistance Of Non-Ketotic Diabetes MellitusNational Center For Research Resources1985–1986
- Effect Of Circulating Insulin Antibodies On In Vivo Insulin ActionNational Center For Research Resources1985–1986
- Control Of Hepatic Glucose Output In Type II DiabetesNational Center For Research Resources1985
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
